This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Henry H. Balfour, Jr, MD; Janet A. Englund, MD

Am J Dis Child. 1989;143(11):1307-1316.

Abstract
• Pediatricians are made familiar with antiviral drugs and are provided with specific recommendations for treatment of viral diseases. The antiviral drugs in clinical use today are discussed in terms of their doses, routes of administration, mechanisms of action, established and potential efficacies, and toxicities. These drugs include acyclovir, amantadine, trisodium phosphonoformate, ganciclovir, ribavirin, rimantadine, vidarabine, and zidovudine. Biologic response modifiers, such as interferons, are mentioned briefly in their historical context. Future trends in antiviral therapy are anticipated with mention of the most promising candidate compounds currently in preclinical trials.

(AJDC. 1989;143:1307-1316)

Author Affiliations
From the Departments of Laboratory Medicine and Pathology and Pediatrics, University of Minnesota Health Sciences Center, Minneapolis (Dr Balfour), and the Departments of Microbiology and Immunology and Pediatrics, Baylor College of Medicine, Texas Medical Center, Houston (Dr Englund).

Footnotes
Accepted for publication June 21, 1989

Reprint requests to University of Minnesota Health Sciences Center, Box 437 UMHC, Minneapolis, MN 55455 (Dr Balfour).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?